<DOC>
	<DOCNO>NCT00505323</DOCNO>
	<brief_summary>Dystonia neurological movement disorder sustain muscle contraction cause twist repetitive movement abnormal posture . This disease heterogeneous many cause . Current treatment ( drug , pallidal stimulation ) improve primary generalized dystonias ; however ineffective focal dystonias follow brain damage . Cortex stimulation present effective technique use treatment chronic pain could represent interesting strategy treat focal dystonias . This aim present study .</brief_summary>
	<brief_title>Motor Premotor Cortex Stimulation Treatment Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation Safety Effectiveness</brief_title>
	<detailed_description>Pilot study include 6 centre ( Clermont-Ferrand , Bordeaux , Paris , Cr√©teil , Lyon Grenoble ) Study progress : - 3 month 1 month chirurgical intervention : selection patient could include protocol . - 15 day 8 day chirurgical intervention : inclusion visit . - Operating phase : anaesthesia , implantation neurostimulator component , adjustment stimulation parameter . - 1 month chirurgical intervention : checking fine ( detection undesirable event ) - 2 month 5 month chirurgical intervention : randomization ( double blind ) : stimulator put position On OFF - 5 month chirurgical intervention : Stimulators patient stop one month whatever group belong . - 6 month 9 month chirurgical intervention : Stimulatiors put position On OFF ( cross first period ) . - 9 month 13 month chirurgical intervention : Stimulators patient start four month whatever group belong . - 13 month chirurgical intervention : study end</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>Age : &gt; 18 year &lt; 65 year Evolution time dystonia &gt; 1 year Clinical stability dystonia = 1 year Secondary dystonia due focal lesion ( vascular anoxic ) central grey nuclei Inefficiency others treatment ( anticholinergic , benzodiazepine , neuroleptique , botulinum toxin , etc . ) Stability treatment &gt; 3 month Agreement patient Affiliation social security Significant heart vascular disease ; significant respiratory , metabolic , renal hepatic disease Significant clinical biological anomaly Disease treatment favour bleed Sever cognitive disorder Psychiatric evolutionary pathology Counterindication inclusion examination Chirurgical counterindication Pregnant woman ou woman nurse Person participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cortex stimulation</keyword>
	<keyword>Focal secondary Dystonia</keyword>
	<keyword>Effectiveness</keyword>
	<keyword>Quality life improvement</keyword>
	<keyword>Focal dystonias secondary central grey nuclei lesion</keyword>
</DOC>